1st Department of Dermatology School of Medicine Faculty of Health Sciences Aristotle University of Thessaloniki Thessaloniki Greece

Carol Davila University of Medicine and Pharmacy Bucharest Bucharest Romania

Department of Dermatology and Allergy School of Medicine German Cancer Consortium Technical University of Munich Munich Germany

Department of Dermatology Instituto Valenciano de Oncología Valencia Spain

Department of Dermatology Medical University of Warsaw Warsaw Poland

Department of Dermatology University Hospital Carl Gustav Carus TU Dresden Dresden Germany

Department of Dermatovenereology 3rd Faculty of Medicine Charles University and Kralovske Vinohrady University Hospital Prague Czech Republic

Department of Oncotherapy Department of Dermatology and Allergology University of Szeged Szeged Hungary

Dermatologia Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italy

Faculty of Medicine Sigmund Freud University Vienna Vienna Austria

Oncologic Dermatology Department Elias University Hospital Bucharest Bucharest Romania

School of Medicine Universidad Católica de Valencia San Vicente Mártir Valencia Spain

Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases Dresden Germany

UOC di Dermatologia Università Cattolica del Sacro Cuore Rome Italy

See more in PubMed

ESMO, Cancer patient management during the covid‐19 pandemic. URL: https://www.esmo.org/guidelines/cancer‐patient‐management‐during‐the‐covid‐19‐pandemic?hit=ehp (last accessed: 22 December 2020).

NCCN . Short‐Term Recommendations for Cutaneous Melanoma Management During COVID‐19 Pandemic. URL: https://www.nccn.org/covid‐19/pdf/Melanoma.pdf (last accessed: 06 May 2020).

Garbe C, Amaral T, Peris K et al. European consensus‐based interdisciplinary guideline for melanoma. Part 2: treatment e update 2019. Eur J Cancer 2020; 126: 159–177. PubMed

Oude Ophuis CM, Verhoef C, Rutkowski P et al. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients ‐ An EORTC Melanoma Group study. Eur J Surg Oncol 2016; 42: 1906–1913. PubMed

Tejera‐Vaquerizo A, Descalzo‐Gallego MA, Traves V. The intriguing effect of delay time to sentinel lymph node biopsy on survival: a propensity score matching study on a cohort of melanoma patients. Eur J Dermatol 2017; 27: 487–495. PubMed

Tejera‐Vaquerizo A, Nagore E, Puig S et al. Effect of time to sentinel‐node biopsy on the prognosis of cutaneous melanoma. Eur J Cancer 2015; 51: 1780–1793. PubMed PMC

Faries MB, Thompson JF, Cochran AJ et al. Completion dissection or observation for sentinel‐node metastasis in melanoma. N Engl J Med 2017; 376: 2211–2222. PubMed PMC

Nahm SH, Rembielak A, Peach H et al. Consensus guidelines for the management of melanoma during the COVID‐19 pandemic: surgery, systemic anti‐cancer therapy, radiotherapy and follow‐up. Clin Oncol 2021; 33: e54–e57. PubMed PMC

Rogiers A, Pires da Silva I, Tentori C et al. Clinical impact of COVID‐19 on patients with cancer treated with immune checkpoint inhibition. J Immunother Cancer 2021; 9: e001931. PubMed PMC

Garassino MC, Giesen N, Grivas P et al. COVID‐19 vaccination in cancer patients: ESMO statements. URL https://www.esmo.org/covid‐19‐and‐cancer/covid‐19‐vaccination (last accessed: 22 December 2020).